Five things to know about medtech deals in the first quarter:
- In quarter one, $1.8 billion was tracked in medtech deal activity, with $7.4 billion in investments over the past year. This is a decline of 31 percent compared to the year prior.
- According to the report, there were 439 venture capital deals in the medtech industry with a combined deal value of $8.7 billion in 2022. This is down from 561 deals and deal value of $9.7 billion in 2021.
- There have been only 16 buyouts in medtech since the start of 2023.
- Inflation, higher interest rates and a frozen IPO market are some contributing factors to a decline in venture capital and private equity activity in medtech.
- Oncology diagnostics, AI-powered medical imaging and remote patient monitoring are the three areas in which medtech funding is increasing.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
